ctrl K

Intensity Therapeutics In... (INTS)

NASDAQ: INTS · Real-Time Price · USD

0.56

0.00 (0.18%)

At close: May 02, 2025, 3:06 PM

Intensity Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2.59M	8.56M	1.31M	4.54M	9.32M	3.83M
Short-Term Investments	n/a	6.22M	n/a	n/a	n/a	4.56M
Long-Term Investments	n/a	n/a	n/a	n/a	50K	75K
Other Long-Term Assets	1.3M	1.68M	167.74K	167.74K	-18.3K	-45.56K
Receivables	n/a	n/a	62.3K	51.26K	67.81K	33.63K
Inventory	n/a	n/a	29.36K	70.44K	217.17K	205.47K
Other Current Assets	n/a	6K	46.8K	69.28K	176.88K	166.47K
Total Current Assets	3.36M	15.46M	1.45M	4.73M	9.63M	8.65M
Property-Plant & Equipment	122K	147K	139.09K	318.13K	490.24K	252.67K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.42M	1.83M	306.83K	485.86K	521.94K	282.11K
Total Assets	4.78M	17.3M	1.76M	5.22M	10.15M	8.93M
Account Payables	1.22M	3.05M	603K	172.51K	222.71K	393.96K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	28K	n/a	4.35M	2.02M	n/a	n/a
Other Current Liabilities	56K	499K	-655	n/a	n/a	n/a
Total Current Liabilities	1.75M	3.96M	6.82M	3.72M	1.35M	1.13M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	36K	10.04M	10.04M	10.04M	10.04M
Total Long-Term Liabilities	110K	174K	10.04M	10.18M	10.36M	10.18M
Total Liabilities	1.86M	4.13M	16.85M	13.9M	11.71M	11.31M
Total Debt	138K	158K	4.49M	2.34M	497.48K	260.27K
Common Stock	2K	1K	341.00	682.00	682.00	681.00
Retained Earnings	-66.78M	-50.52M	-38.65M	-31.07M	-23.18M	-17.15M
Comprehensive Income	n/a	n/a	n/a	-31.07M	-23.18M	-17.15M
Shareholders Equity	2.92M	13.16M	-15.1M	-8.68M	-1.56M	-2.38M
Total Investments	n/a	6.22M	n/a	n/a	50K	4.56M